Skip to main content

Packaging, labelling and marketing of pharmaceuticals has evolved rapidly in India, with concerns about ‘deceptive similarity’ at the helm. Our Pharma Dossier (Vol. 1) discusses trade mark jurisprudence in light of the primary factor – the consumer.

Whereas differentiation on the basis of a name may have become more constrictive, creative use of unconventional marks and branding exercises by pharmaceutical companies has aided the creation of unique identities. Useful, with the rate e-pharmacies are disrupting traditional distribution models.

 

To read more, contact us at email@anandandanand.com

Most Recent

News & Insights

VIEW ALL
Thought Leadership
Dec 19, 2025

First published on Express Computer. Authored by Subroto Kumar Panda The notification of the Digital Personal Data Protection (DPDP) Rules, 2025, marks

The DPDP: An 18-month compliance imperative for the C-suite
News & Updates, Thought Leadership
Dec 16, 2025

‘First published on India Business Law Journal’ By: Pravin Anand and Dr. Ajai Garg Artificial Intelligence (AI) is fuelling one of the most significant

Law can keep us safe from superintelligence
News & Updates
Dec 05, 2025

The High Court of Delhi in a significant interim ruling, “AB SKF vs M/S PARAMOUNT BEARING CO. & ORS.”, CS(COMM) 963/2025, dated 19/11/2025 has clarified

Distinction Between Order 38, Rule 5 and Order 39, Rules 1-2 CPC in the Context of “Maintenance of Status Quo”
News & Updates
Nov 26, 2025

Authored by Pravin Anand There are areas of intellectual property law where one can sense, quite literally, the convergence of disciplines that do not

When Art Meets Science in Trademark Law: Reflections on India’s First Smell Mark